TEVA-LIOTHYRONINE TABLET

国家: 加拿大

语言: 英文

来源: Health Canada

有效成分:

LIOTHYRONINE (LIOTHYRONINE SODIUM)

可用日期:

TEVA CANADA LIMITED

ATC代码:

H03AA02

INN（国际名称）:

LIOTHYRONINE SODIUM

剂量:

25MCG

药物剂型:

TABLET

组成:

LIOTHYRONINE (LIOTHYRONINE SODIUM) 25MCG

给药途径:

ORAL

每包单位数:

15G/50G

处方类型:

Prescription

治疗领域:

THYROID AGENTS

產品總結:

Active ingredient group (AIG) number: 0102421002; AHFS:

授权状态:

APPROVED

授权日期:

2019-11-21

产品特点

_ _
_Teva-Liothyronine Tablets _
_Page 1 of 17_
PRODUCT MONOGRAPH
Pr
TEVA-LIOTHYRONINE
Liothyronine Sodium Tablets
5 mcg and 25 mcg liothyronine as liothyronine sodium
USP
Hypothyroidism Therapy
Teva Canada Limited
30 Novopharm Court
Toronto, Ontario
M1B 2K9
Date of Approval:
November 20, 2019
Submission Control No: 217318
_ _
_Teva-Liothyronine Tablets _
_Page 2 of 17_
TABLE OF CONTENTS
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................6
DRUG INTERACTIONS
....................................................................................................7
DRUG/LABORATORY TEST INTERACTIONS
.............................................................9
DOSAGE AND ADMINISTRATION
..............................................................................10
OVERDOSAGE
................................................................................................................11
ACTION
............................................................................................................................12
CLINICAL PHARMACOLOGY
......................................................................................12
SUPPLY
.............................................................................................................................15
COMPOSITION
................................................................................................................15
PART III: CONSUMER INFORMATION
......................................................................16
_ _
_Teva-Liothyronine Tablets _
_Page 3 of 17_
Pr
TEVA-LIOTHYRONINE
liothyronine sodium
INDICATIONS AND CLINICAL USE
TEVA-LIOTHYRONINE is